Short Collagen Fibers Provide Control of Contraction and Permeability in Fibroblast-Seeded Collagen Gels

Tissue Engineering

Volumn 10, Issue 3-4, 2004, Pages 421-427

  Gentleman, E ^a   Nauman, E A ^a   Dee, K C ^a   Livesay, Glen A ^a  

^a TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; COLLAGEN GEL; COLLAGEN TYPE 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; BIODEGRADABILITY; CELL PROLIFERATION; CELL VIABILITY; COMPOSITE GRAFT; CONFERENCE PAPER; CONTROLLED STUDY; DIFFUSION; FIBROBLAST; FLUORESCENCE MICROSCOPY; NONHUMAN; NUTRIENT; PERMEABILITY; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

CELL SURVIVAL; COLLAGEN; FIBROBLASTS; HUMANS; PERMEABILITY; TIME FACTORS; TISSUE ENGINEERING;

EID: 2342539025     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/107632704323061780     Document Type: Conference Paper

References (43)

1. Bellincampi, L.D., Closkey, R.F., Prasad, R., Zawadsky, J.P., and Dunn, M.G. Viability of fibroblast-seeded ligament analogs after autogenous implantation. J. Orthop. Res. 16, 414, 1998.
2. Dunn, M.G., Liesch, J.B., Tiku, M.L., and Zawadsky, J.P. Development of fibroblast-seeded ligament analogs for ACL reconstruction. J. Biomed. Mater. Res. 29, 1363, 1995.
3. Nehrer, S., Breinan, H.A., Ramappa, A., Hsu, H.P., Minas, T., Shortkroff, S., Sledge, C.B., Yannas, I.V., and Spector, M. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials 19, 2313, 1998.
4. Murray, M.M., and Spector, M. The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro. Biomaterials 22, 2393, 2001.
5. Torres, D.S., Freyman, T.M., Yannas, I.V., and Spector, M. Tendon cell contraction of collagen-GAG matrices in vitro: Effect of cross-linking. Biomaterials 21, 1607, 2000.
6. Martin, I., Obradovic, B., Treppo, S., Grodzinsky, A.J., Langer, R., Freed, L.E., and Vunjak-Novakovic, G. Modulation of the mechanical properties of tissue engineered cartilage. Biorheology 37, 141, 2000.
7. Hunter, C.J., Imler, S.M., Malaviya, P., Nerem, R.M., and Levenston, M.E. Mechanical compression alters gene expression and extracellular matrix synthesis by chondrocytes cultured in collagen I gels. Biomaterials 23, 1249, 2002.
8. Frerich, B., Lindemann, N., Kurtz-Hoffmann, J., and Oertel, K. In vitro model of a vascular stroma for the engineering of vascularized tissues. Int. J. Oral. Maxillofac. Surg. 30, 414, 2001.
9. Wang, H.L., and Carroll, W.J. Using absorbable collagen membranes for guided tissue regeneration, guided bone regeneration, and to treat gingival recession. Compend. Contin. Educ. Dent. 21, 399, 2000.
10. Hafemann, B., Ghofrani, K., Gattner, H.-G., Stieve, H., and Pallua, N. Cross-linking by 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) of a collagen/elastin membrane meant to be used as a dermal substitute: Effects on physical, biochemical and biological features in vitro. J. Mater. Sci. Mater. Med. 12, 437, 2001.
11. Weadock, K., Olson, R.M., and Silver, F.H. Evaluation of collagen crosslinking techniques. Biomater. Med. Devices Artif. Organs 11, 293, 1983.
12. Chvapil, M. Reconstituted collagen. In: A. Viidik and J. Vuust, eds. Biology of Collagen. London: Academic Press, 1980, pp. 313-325.
13. Houck, J., and Chang, C. The chemotactic properties of the products of collagenolysis. Proc. Soc. Exp. Biol. Med. 138, 69, 1971.
14. Postlethwaite, A.E., Seyer, J.M., and Kang, A.H. Chemotactic attraction of human fibroblasts to type I, II, and III collagens and collagen-derived peptides. Proc. Natl. Acad. Sci. U.S.A. 75, 871, 1978.
15. Zhu, Y.K., Umino, T., Liu, X.D., Wang, H.J., Romberger, D.J., Spurzem, J.R., and Rennard, S.I. Effect of initial collagen concentration on fibroblast mediated contraction of collagen gels. Chest 117, S234, 2000.
16. Nakagawa, S., Pawelek, P., and Grinnell, F. Long-term culture of fibroblasts in contracted collagen gels: Effects on cell growth and biosynthetic activity. J Invest Dermatol. 93, 792, 1989.
17. Ohsawa, S., Yasui, N., and Ono, K. Contraction of collagen gel by the dedifferentiated chondrocytes. Cell Biol. Int. Rep. 6, 767, 1982.
18. Rompre, P., Auger, F.A., Germain, L., Bouvard, V., Lopez Valle, C.A., Thibault, J., and Le Duy, A. Influence of initial collagen and cellular concentrations on the final surface area of dermal and skin equivalents: A Box-Behnken analysis. In Vitro Cell. Dev. Biol. 26, 983, 1990.
19. Vaissiere, G., Chevallay, B., Herbage, D., and Damour, O. Comparative analysis of different collagen-based biomaterials as scaffolds for long-term culture of human fibroblasts. Med. Biol. Eng. Comput. 38, 205, 2000.
20. Bell, E., Ivarsson, B., and Merrill, C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. U.S.A. 76, 1274, 1979.
21. 1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils. J. Cell Biol. 115, 1427, 1991.
22. Mio, T., Adachi, Y., Romberger, D.J., Ertl, R.F., and Rennard, S.I. Regulation of fibroblast proliferation in three-dimensional collagen gel matrix. In Vitro Cell. Dev. Biol. Anim. 32, 427, 1996.
23. Zhu, Y.K., Umino, T., Liu, X.D., Wang, H.J., Romberger, D.J., Spurzem, J.R., and Rennard, S.I. Contraction of fibroblast-containing collagen gels: Initial collagen concentration regulates the degree of contraction and cell survival. In Vitro Cell. Dev. Biol. Anim. 37, 10, 2001.
24. Auger, F.A., Rouabhia, M., Goulet, F., Berthod, F., Moulin, V., and Germain, L. Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: Clinical and fundamental applications. Med. Biol. Eng. Comput. 36, 801, 1998.
25. Lin, Y.C., and Grinnell, F. Treatment of human fibroblasts with vanadate and platelet-derived growth factor in the presence of serum inhibits collagen matrix contraction. Exp. Cell Res. 221, 73, 1995.
26. Mio, T., Adachi, Y., Carnevali, S., Romberger, D.J., Spurzem, J.R., and Rennard, S.I. β-Adrenergic agonists attenuate fibroblast-mediated contraction of released collagen gels. Am. J. Physiol. 270, L829, 1996.
27. Lopez Valle, C.A., Auger, F.A., Rompre, P., Bouvard, V., and Germain, L. Peripheral anchorage of dermal equivalents. Br. J. Dermatol. 127, 365, 1992.
28. Moullier, P., Danos, O., Heard, J.-M., and Ferry, N. Biocompatible implant for the expression and in vivo secretion of a therapeutic substance. Patent issued to Institut Pasteur, United States, 1999.
29. Jones, R.M. Mechanics of Composite Materials. New York: McGraw-Hill, 1975.
30. Piggott, M. Load Bearing Fibre Composites. Boston, MA: Kluwer Academic, 2002.
31. Kato, Y.P., Christiansen, D.L., Hahn, R.A., Shieh, S.J., Goldstein, J.D., and Silver, F.H. Mechanical properties of collagen fibres: A comparison of reconstituted and rat tail tendon fibres. Biomaterials 10, 38, 1989.
32. Goldstein, J.D., Tria, A.J., Zawadsky, J.P., Kato, Y.P., Christiansen, D., and Silver, F.H. Development of a reconstituted collagen tendon prosthesis: A preliminary implantation study. J. Bone Joint Surg. Am. 71, 1183, 1989.
33. Dunn, M.G., Tria, A.J., Kato, Y.P., Bechler, J.R., Ochner, R.S., Zawadsky, J.P., and Silver, F.H. Anterior cruciate ligament reconstruction using a composite collagenous prosthesis: A biomechanical and histologic study in rabbits. Am. J. Sports Med. 20, 507, 1992.
34. Dunn, M.G., Avasarala, P.N., and Zawadsky, J.P. Optimization of extruded collagen fibers for ACL reconstruction. J. Biomed. Mater. Res. 27, 1545, 1993.
35. Law, J.K., Parsons, J.R., Silver, F.H., and Weiss, A.B. An evaluation of purified reconstituted type I collagen fibers. J. Biomed. Mater. Res. 23, 961, 1989.
36. Dunn, M.G., Maxian, S.H., and Zawadsky, J.P. Intraosseous incorporation of composite collagen prostheses designed for ligament reconstruction. J. Orthop. Res. 12, 128, 1994.
37. Wasserman, A.J., Kato, Y.P., Christiansen, D., Dunn, M.G., and Silver, F.H. Achilles tendon replacement by a collagen fiber prosthesis: Morphological evaluation of neotendon formation. Scanning Microsc. 3, 1183, 1989.
38. Fleiss, J.L. The Design and Analysis of Clinical Experiments. Portland, OR: John Wiley & Sons, 1986.
39. Hui, P.W., Leung, P.C., and Sher, A. Fluid conductance of cancellous bone graft as a predictor for graft-host interface healing. J. Biomech. 29, 123, 1996.
40. Li, G.P., Bronk, J.T., An, K.N., and Kelly, P.J. Permeability of cortical bone of canine tibiae. Microvasc. Res. 34, 302, 1987.
41. Katz, A.J., Llull, R., Hedrick, M.H., and Futrell, J.W. Emerging approaches to the tissue engineering of fat. Clin. Plast. Surg. 26, 587, 1999.
42. Patrick, C.W., Jr., Chauvin, P.B., and Robb, G.L. Tissue engineered adipose tissue. In: CW. Patrick, Jr., A.G. Mikos, and L.V. McIntire, eds. Frontiers in Tissue Engineering. New York: Elsevier Sciences, 1998, pp. 369-382.
43. Kato, Y.P., Dunn, M.G., Zawadsky, J.P., Tria, A.J., and Silver, F.H. Regeneration of Achilles tendon with a collagen tendon prosthesis: Results of a one-year implantation study. J. Bone Joint Surg. Am. 73, 561, 1991.